The Diagnostic Imaging MRI modality focus page provides information, videos, podcasts, and the latest news about industry product developments, trial results, screening guidelines, and protocol guidance that touch on the use of MRI across the healthcare continuum, including breast, neurological, cardiovascular, prostate imaging, and more.

Latest News

FDA Clears Virtually Helium-Free 1.5T MRI System from Siemens Healthineers
FDA Clears Virtually Helium-Free 1.5T MRI System from Siemens Healthineers

June 26th 2025

Offering a cost- and resource-saving DryCool magnet technology, the Magnetom Flow.Ace MRI system reportedly requires 0.7 liters of liquid helium for cooling over the lifetime of the device in contrast to over 1,000 liters commonly utilized with conventional MRI platforms.

Can Contrast-Enhanced Mammography be a Viable Screening Alternative to Breast MRI?
Can Contrast-Enhanced Mammography be a Viable Screening Alternative to Breast MRI?

June 17th 2025

Multinational Study Reaffirms Value of Adjunctive AI for Prostate MRI
Multinational Study Reaffirms Value of Adjunctive AI for Prostate MRI

June 16th 2025

FDA Clears Enhanced MRI-Guided Laser Ablation System
FDA Clears Enhanced MRI-Guided Laser Ablation System

June 5th 2025

Study: AI-Generated ADC Maps from MRI More Than Double Specificity in Prostate Cancer Detection
Study: AI-Generated ADC Maps from MRI More Than Double Specificity in Prostate Cancer Detection

June 5th 2025

Video Interviews
Latest CME Events & Activities

PER Tumor Board®: Applying Recent Advances to Transform the Treatment Paradigm in SCLC—Expert Perspectives on New Approvals and Emerging Strategies

View More

Lung Cancer Tumor Board®: How Do Emerging Data for ICIs, BiTEs, ADCs, and Targeted Strategies Address Unmet Needs in the Therapeutic Continuum for SCLC?

View More

26th Annual International Lung Cancer Congress®

July 25-26, 2025

Register Now!

2025 International Symposium of Gastrointestinal Oncology (ISGIO)

September 12-13, 2025

Register Now!

Lung Cancer Tumor Board: Enhancing Precision Medicine in NSCLC Through Advancements in Molecular Testing and Optimal Therapy Selection

View More

(CME Credit Only) Lung Cancer Tumor Board®: The Pivotal Role of Multimodal Therapy in Leveraging Immunotherapy for Stage I-III NSCLC When the Goal Is Cure

View More

(MOC and CME Credit) Lung Cancer Tumor Board®: The Pivotal Role of Multimodal Therapy in Leveraging Immunotherapy for Stage I-III NSCLC When the Goal Is Cure

View More

(CME Credit Only) New Frontiers in Immunotherapy for SCLC: Insights From Latest Clinical Trials and Their Application in Real-World Treatment

View More

(MOC and CME Credit) New Frontiers in Immunotherapy for SCLC: Insights From Latest Clinical Trials and Their Application in Real-World Treatment

View More

43rd Annual CFS®: Innovative Cancer Therapy for Tomorrow™

November 12-14, 2025

Register Now!

20th Annual New York Lung Cancers Symposium®

November 15, 2025

Register Now!

2nd Annual Hawaii Cancer Conference

January 24-25, 2026

Register Now!

23rd Annual Winter Lung Cancer Conference®

January 23-25, 2026

Register Now!

43rd Annual Miami Breast Cancer Conference®

March 5-8, 2026

Register Now!

19th Annual New York GU Cancers Congress™

March 13-14, 2026

Register Now!

Mastering Advances in Managing Unresectable and Metastatic NSCLC—Immunotherapy, Targeted Therapies, and Emerging Strategies

View More

Cases & Conversations™: Expert Perspectives on Leveraging Recent Advances to Transform SCLC Treatment

View More

Community Practice Connections™: Empowering Interventional Radiologists in the Emerging Era of Oncolytic Immunotherapies for Melanoma

View More

(CME Credit) Advancing Outcomes in Limited-Stage Small Cell Lung Cancer: From Evidence to Practice

View More

More News

© 2025 MJH Life Sciences

All rights reserved.